Association between CYP2C19 polymorphism and depressive symptoms

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 6, 2010, Pages 1160-1166

  Sim, Sarah C ^a   Nordin, Linn ^a   Andersson, Therese M L ^a   Virding, Susanne ^a   Olsson, Marita ^a,b   Pedersen, Nancy L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Depressed mood; Neurosteroids; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOCHROME P450 2C19; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; DEPRESSION; DRUG METABOLISM; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SWEDEN;

AGED; AGED, 80 AND OVER; AGING; ANTIDEPRESSIVE AGENTS; ARYL HYDROCARBON HYDROXYLASES; DEPRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; SWEDEN;

EID: 77956108814     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31081     Document Type: Article

References (34)

1. Baldwin RM, Ohlsson S, Pedersen RS, Mwinyi J, Ingelman-Sundberg M, Eliasson E, Bertilsson L. 2008. Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers. Br J Clin Pharmacol 65:767-774.
2. Beekman AT, Deeg DJ, Van Limbeek J, Braam AW, De Vries MZ, Van Tilburg W. 1997. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): Results from a community-based sample of older subjects in The Netherlands. Psychol Med 27:231-235.
3. Butura A, Nilsson K, Morgan K, Morgan TR, French SW, Johansson I, Schuppe-Koistinen I, Ingelman-Sundberg M. 2009. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol 50:572-583.
4. Cheng ZN, Shu Y, Liu ZQ, Wang LS, Ou-Yang DS, Zhou HH. 2001. Role of cytochrome P450 in estradiol metabolism in vitro. Acta Pharmacol Sin 22:148-154. (Pubitemid 32158354)
5. Cribb AE, Knight MJ, Dryer D, Guernsey J, Hender K, Tesch M, Saleh TM. 2006. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cancer Epidemiol Biomarkers Prev 15:551-558.
6. Desta Z, Zhao X, Shin JG, Flockhart DA. 2002. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet 41:913-958. (Pubitemid 35168437)
7. Finkel D, Pedersen NL. 2004. Processing speed and longitudinal trajectories of change for cognitive abilities: The Swedish Adoption/Twin Study of Aging. Aging Neuropsychol Cogn 11:325-345. (Pubitemid 39387207)
8. Fiske A, Gatz M, Pedersen NL. 2003. Depressive symptoms and aging: The effects of illness and non-health-related events. J Gerontol B Psychol Sci Soc Sci 58:P320-P328. (Pubitemid 37467312)
9. Fradette C, Yamaguchi N, Du Souich P. 2004. 5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide. Br J Pharmacol 141:407-414. (Pubitemid 38297003)
10. Fukasawa T, Suzuki A, Otani K. 2007. Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines. J Clin Pharm Ther 32:333-341. (Pubitemid 47063159)
11. Gatz M, Johansson B, Pedersen N, Berg S, Reynolds C. 1993. A cross-national self-report measure of depressive symptomatology. Int Psychogeriatr 5:147-156. (Pubitemid 23362839)
12. Gold CH, Malmberg B, McClearn GE, Pedersen NL, Berg S. 2002. Gender and health: A study of older unlike-sex twins. J Gerontol B Psychol Sci Soc Sci 57:S168-S176. (Pubitemid 34465256)
13. Ingelman-Sundberg M, Johansson I. 1984. Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. J Biol Chem 259:6447-6458. (Pubitemid 14108194)
14. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. 2007. Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496-526. (Pubitemid 350116943)
15. Ishii G, Suzuki A, Oshino S, Shiraishi H, Otani K. 2007. CYP2C19 polymorphism affects personality traits of Japanese females. Neurosci Lett 411:77-80. (Pubitemid 44751944)
16. Jansson M, Gatz M, Berg S, Johansson B, Malmberg B, McClearn GE, Schalling M, Pedersen NL. 2003. Association between depressed mood in the elderly and a 5-HTR2A gene variant. Am J Med Genet Part B 120B:79-84.
17. Kendler KS, Gatz M, Gardner CO, Pedersen NL. 2006. A Swedish national twin study of lifetime major depression. Am J Psychiatry 163:109-114.
18. Kendler KS, Gatz M, Gardner CO, Pedersen NL. 2007. Clinical indices of familial depression in the Swedish Twin Registry. Acta Psychiatr Scand 115:214-220.
19. Kronmuller KT, Pantel J, Kohler S, Victor D, Giesel F, Magnotta VA, Mundt C, Essig M, Schroder J. 2008. Hippocampal volume and 2-year outcome in depression. Br J Psychiatry 192:472-473. (Pubitemid 351809903)
20. Kurzawski M, Gawronska-Szklarz B, Wrzesniewska J, Siuda A, Starzynska T, Drozdzik M. 2006. Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients. Eur J Clin Pharmacol 62:877-880. (Pubitemid 44521437)
21. McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA, Plomin R. 1997. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 276:1560-1563. (Pubitemid 27255319)
22. Ohlsson Rosenborg S, Mwinyi J, Andersson M, Baldwin RM, Pedersen RS, Sim SC, Bertilsson L, Ingelman-Sundberg M, Eliasson E. 2008. Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects. Eur J Clin Pharmacol 64:1175-1179.
23. Pedersen NL, McClearn GE, Plomin R, Nesselroade JR, Berg S, DeFaire U. 1991. The Swedish Adoption Twin Study of Aging: An update. Acta Genet Med Gemellol (Roma) 40:7-20.
24. Pinna G, Costa E, Guidotti A. 2009. SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol 9:24-30.
25. Radloff LS. 1977. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1:385-401.
26. Rudberg I, Hermann M, Refsum H, Molden E. 2008a. Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients. Eur J Clin Pharmacol 64:1181-1188.
27. Rudberg I, Mohebi B, Hermann M, Refsum H, Molden E. 2008b. Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients. Clin Pharmacol Ther 83:322-327.
28. Savaskan E, Muller SE, Bohringer A, Schulz A, Schachinger H. 2008. Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients. Int J Neuropsychopharmacol 11:381-388. (Pubitemid 351482500)
29. Schroth W, Antoniadou L, Fritz P, Schwab M, Muerdter T, Zanger UM, Simon W, Eichelbaum M, Brauch H. 2007. Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes. J Clin Oncol 25:5187-5193. (Pubitemid 350232249)
30. Sim SC, Risinger C, Dahl ML, Aklillu E, Christensen M, Bertilsson L, Ingelman-Sundberg M. 2006. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther 79:103-113. (Pubitemid 43069582)
31. Suthers KM, Gatz M, Fiske A. 2004. Screening for depression: A comparative analysis of the 11-item CES-D and the CIDI-SF. J Mental Health Aging 10:209-219. (Pubitemid 41094437)
32. Yamazaki H, Shimada T. 1997. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys 346:161-169. (Pubitemid 27415307)
33. Yasui-Furukori N, Kaneda A, Iwashima K, Saito M, Nakagami T, Tsuchimine S, Kaneko S. 2007. Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese. Am J Med Genet B Neuropsychiatr Genet 144B:724-727. (Pubitemid 47417199)
34. Yin OQ, Wing YK, Cheung Y, Wang ZJ, Lam SL, Chiu HF, Chow MS. 2006. Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients. J Clin Psychopharmacol 26:367-372. (Pubitemid 44192092)